Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Alzheimer's
disease
(AD)
is
a
complex
neurodegenerative
disorder
with
an
unclear
pathogenesis;
the
traditional
″single
gene-single
target-single
drug″
strategy
insufficient
for
effective
treatment.
This
study
explores
novel
multitarget
therapy
of
AD
by
integrating
multiomics
data
and
employing
network
analysis.
Different
from
conventional
single-target
methods,
TCnet
adopts
mechanism-driven
strategy,
utilizing
to
decompose
mechanisms,
construct
potential
target
combinations,
prioritize
optimal
combinations
using
scoring
function.
not
only
advances
our
understanding
mechanisms
but
also
facilitates
large-scale
drug
screening.
approach
was
further
employed
screen
active
compounds
Huang-Lian-Jie-Du-Tang
(HLJDT),
identifying
quercetin
as
candidate
targeting
GSK3β
ADAM17.
Subsequent
in
vitro
experiments
confirmed
neuroprotective
anti-inflammatory
effects
quercetin.
Overall,
offers
promising
predicting
provides
new
insights
directions
discovery
AD.
Diseases,
Journal Year:
2024,
Volume and Issue:
12(8), P. 184 - 184
Published: Aug. 16, 2024
Background:
Alzheimer’s
disease
(AD)
is
a
neurodegenerative
characterized
by
beta-amyloid
(Aβ)
deposition
and
increased
acetylcholinesterase
(AchE)
enzyme
activities.
Indole
3
carbinol
(I3C)
diindolylmethane
(DIM)
are
reported
to
have
neuroprotective
activities
against
various
neurological
diseases,
including
ischemic
stroke,
Parkinson’s
disease,
neonatal
asphyxia,
depression,
stress,
neuroinflammation,
excitotoxicity,
except
for
AD.
In
the
present
study,
we
investigated
anti-AD
effects
of
I3C
DIM.
Methods:
Docking
molecular
dynamic
studies
AchE
network
pharmacological
were
conducted
DIM’s
self
AchE-induced
Aβ
aggregation
investigated.
The
DIM
Aβ-induced
neurotoxicity
assessed
in
SH-S5Y5
cells
observing
cell
viability
ROS.
Results:
with
show
binding
efficiency
−7.0
−10.3,
respectively,
dynamics
revealed
better
interaction
stability
between
AchE.
Network
indicated
that
interacted
several
proteins
involved
pathophysiology
Further,
significantly
inhibited
(IC50:
(18.98
µM)
(11.84
µM))
self-induced
aggregation.
Both
compounds
enhanced
exposed
reduced
equipotential
neuroprotection
when
compared
donepezil.
Conclusions:
Our
findings
indicate
both
inhibiting
induced
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Aug. 2, 2024
Abstract
Neurodegenerative
disorders
are
complex,
progressive,
and
life-threatening.
They
cause
mortality
disability
for
millions
of
people
worldwide.
Appropriate
treatment
neurodegenerative
diseases
(NDs)
is
still
clinically
lacking
due
to
the
presence
blood-brain
barrier
(BBB).
Developing
an
effective
transport
system
that
can
cross
BBB
enhance
therapeutic
effect
neuroprotective
agents
has
been
a
major
challenge
NDs.
Exosomes
endogenous
nano-sized
vesicles
naturally
carry
biomolecular
cargoes.
Many
studies
have
indicated
exosome
content,
particularly
microRNAs
(miRNAs),
possess
biological
activities
by
targeting
several
signaling
pathways
involved
in
apoptosis,
inflammation,
autophagy,
oxidative
stress.
Exosome
content
influence
cellular
function
healthy
or
pathological
ways.
Furthermore,
since
exosomes
reflect
features
parental
cells,
their
cargoes
offer
opportunities
early
diagnosis
intervention
diseases.
unique
characteristics
make
them
ideal
delivering
drugs
directly
brain.
These
include
ability
pass
through
BBB,
biocompatibility,
stability,
innate
properties.
This
review
emphasizes
role
alleviating
NDs
discusses
associated
molecular
mechanisms.
exosomes,
making
promising
natural
transporter
various
medications
brain
combat
NDs,
also
discussed.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(2), P. 124 - 124
Published: Feb. 13, 2025
Neurodegenerative
diseases
comprise
a
group
of
chronic,
usually
age-related,
disorders
characterized
by
progressive
neuronal
loss,
deformation
structure,
or
loss
function,
leading
to
substantially
reduced
quality
life.
They
remain
significant
focus
scientific
and
clinical
interest
due
their
increasing
medical
social
importance.
Most
neurodegenerative
present
intracellular
protein
aggregation
extracellular
deposition
(plaques),
such
as
α-synuclein
in
Parkinson's
disease
amyloid
beta
(Aβ)/tau
aggregates
Alzheimer's.
Conventional
treatments
for
conditions
incur
high
costs
are
related
the
development
several
adverse
effects.
In
addition,
many
patients
irresponsive
them.
For
these
reasons,
there
is
growing
tendency
find
new
therapeutic
approaches
help
patients.
This
review
intends
investigate
some
phytocompounds'
effects
on
diseases.
These
generally
increased
oxidative
stress
inflammation,
so
phytocompounds
can
prevent
treat
To
achieve
our
aim
provide
critical
assessment
current
literature
about
phytochemicals
targeting
neurodegeneration,
we
reviewed
reputable
databases,
including
PubMed,
EMBASE,
COCHRANE,
seeking
trials
that
utilized
against
conditions.
A
few
investigated
humans,
after
screening,
13
were
ultimately
included
following
PRISMA
guidelines.
compounds
include
polyphenols
(flavonoids
luteolin
quercetin,
phenolic
acids
rosmarinic
acid,
ferulic
caffeic
other
like
resveratrol),
alkaloids
(such
berberine,
huperzine
A,
caffeine),
terpenoids
ginkgolides
limonene).
The
gathered
evidence
underscores
caffeine,
ginkgolides,
primarily
anti-inflammatory,
antioxidant,
neuroprotective,
counteracting
neuroinflammation,
oxidation,
synaptic
dysfunctions,
which
crucial
aspects
intervention
various
conditions,
Alzheimer's
dementias,
depression,
neuropsychiatric
disorders.
summary,
they
show
use
improvements
cognition,
memory,
disinhibition,
irritability/lability,
aberrant
behavior,
hallucinations,
mood
Cell Communication and Signaling,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Jan. 3, 2025
Oxidative
stress
and
neuroinflammation
are
recognized
as
key
factors
in
the
development
of
neurodegenerative
diseases,
yet
effective
interventions
biomarkers
to
address
oxidative
these
conditions
limited.
Uric
acid
(UA),
traditionally
associated
with
gout,
is
now
gaining
prominence
a
potential
target
diseases.
Soluble
UA
stands
out
one
most
vital
antioxidant
compounds
produced
by
human
body,
accounting
for
up
55%
extracellular
capacity
neutralize
free
radicals.
While
there
increasing
evidence
supporting
neuroprotective
properties
Parkinson's
disease
Alzheimer's
disease,
gaps
knowledge
still
exist
regarding
underlying
mechanisms
how
effectively
translate
benefits
into
clinical
practice.
Moreover,
current
elevation
therapy
exhibits
unstable
properties,
individual
variability,
even
adverse
effects,
limiting
its
applications.
This
review
consolidates
recent
advancements
understanding
exerts
effects
on
diseases
emphasizes
dual
roles
managing
neuroinflammation.
Additionally,
elucidates
through
which
confers
neuroprotection.
Based
this,
underscores
significance
biomarker
aims
provide
comprehensive
therapeutic
target,
while
also
addressing
possible
challenges
implementation.
Clinical Epigenetics,
Journal Year:
2025,
Volume and Issue:
17(1)
Published: Jan. 24, 2025
Enriched
environment
(EE),
as
a
non-pharmacological
intervention,
has
garnered
considerable
attention
for
its
potential
to
ameliorate
neurodegenerative
diseases
(NDs).
This
review
delineated
the
impact
of
EE
on
biological
functions
associated
with
NDs,
emphasizing
role
in
enhancing
neural
plasticity,
reducing
inflammation,
and
bolstering
cognitive
performance.
We
discussed
molecular
underpinnings
effects
EE,
including
modulation
key
signaling
pathways
such
extracellular
regulated
kinase
1/2
(ERK1/2),
mitogen-activated
protein
kinases
(MAPK),
AMPK/SIRT1,
which
were
implicated
neuroprotection
synaptic
plasticity.
Additionally,
we
scrutinized
influence
epigenetic
modifications
autophagy,
processes
pivotal
ND
pathogenesis.
Animal
models,
encompassing
both
rodents
larger
animals,
offer
insights
into
disease-modifying
underscoring
complementary
approach
pharmacological
interventions.
In
summary,
emerges
promising
strategy
augment
function
decelerate
progression
NDs.
Applied Biochemistry and Biotechnology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Abstract
Endophytic
fungi
represent
a
significant
renewable
resource
for
the
discovery
of
pharmaceutically
important
compounds,
offering
substantial
potential
new
drug
development.
Their
ability
to
address
growing
issue
resistance
has
drawn
attention
from
researchers
seeking
novel,
nature-derived
lead
molecules
that
can
be
produced
on
large
scale
meet
global
demand.
Recent
advancements
in
genomics,
metabolomics,
bioinformatics,
and
improved
cultivation
techniques
have
significantly
aided
identification
characterization
fungal
endophytes
their
metabolites.
Current
estimates
suggest
there
are
approximately
1.20
million
globally,
yet
only
around
16%
(190,000)
been
identified
studied
detail.
This
underscores
vast
untapped
pharmaceutical
research.
Research
increasingly
focused
transformation
bioactive
compounds
by
through
chemical
enzymatic
processes.
A
notable
example
is
anthraquinone
derivative
6-O-methylalaternin,
whose
cytotoxic
enhanced
addition
hydroxyl
group,
sharing
structural
similarities
with
its
parent
compound
macrosporin.
These
structure-bioactivity
studies
open
up
avenues
developing
safer
more
effective
therapeutic
agents
synthesizing
targeted
derivatives.
Despite
immense
promise,
challenges
remain,
particularly
large-scale
understanding
complexities
biosynthetic
pathways.
Additionally,
genetic
manipulation
optimized
metabolite
production
still
infancy.
Future
research
should
aim
overcome
these
limitations
focusing
efficient
methods
deeper
exploration
endophytes’
metabolic
capabilities
fully
harness
potential.
Graphical
Nutrition and Dietary Supplements,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 19 - 28
Published: Feb. 1, 2025
Introduction:
Stress
and
inflammation
in
the
early
stages
of
cognitive
decline
has
spurred
interest
use
antioxidants
as
prophylactic
therapeutic
agents.
Several
studies
have
established
neuroprotective
capacities
a
pomegranate
oil
nano-formulation
(Nano-PSO).
In
parallel,
cannabis-derived
cannabidiol
(CBD)
prevented
social
recognition
deficits
reduced
neuroinflammation
mice.
This
work
assessed
impact
Nano-PSO:CBD
on
memory
learning.
Methods:
A
battery
hemp
extracts
was
screened
for
their
effects
acetylcholine
esterase
inhibition
neuronal
protection
activities.
The
best-performing
extract
in-vitro
assays
nano-formulated
via
self-emulsifying
system
with
PSO
administered
to
aged
mice
MK-801-induced
decline,
which
were
then
subjected
Morris
water
maze
test
Y-maze
test,
respectively.
Results:
Aged
chronically
fed
performed
22–
31%
shorter
escape
latency
(p
≤
0.05),
23%
distance
swam
increased
average
speed
compared
control
Mice
pretreated
prior
MK-801
had
significantly
higher
percentage
entries
into
novel
arm
untreated
controls.
Discussion:
CBD
salutary
effect
memory,
learning
spatial
should
be
further
studied
clinical
context.
Keywords:
cognition,
nanoformulation,
CBD,
seed
oil,
nano-omega
5,
brain
protect,
punicic
acid